Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Arcturus Therapeutics has raised $9.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Arcturus Therapeutics's investors include Cystic Fibrosis Foundation, Biomedical Advanced Research and Development Authority (BARDA), Japan - The Government of Japan.
Arcturus Therapeutics is headquartered in San Diego, United States.
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Arcturus Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arcturus Therapeutics — Funding & Investors." VCBacked, September 26, 2023, https://www.vcbacked.co/company/arcturus-therapeutics. Accessed September 29, 2026.
VCBacked. (2023). Arcturus Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/arcturus-therapeutics
{{cite web |title=Arcturus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arcturus-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated